IN8BIO INC. - COMMON
0.2550
07-10月-24 15:59:48
15 分の遅延
株式
-0.0083
-3.15%
本日の幅
0.2402 - 0.2760
ISIN
N/A
ソース
NASDAQ
-
IN8bio Highlights Recent Company Accomplishments and Outlines 2024 Pipeline Goals
04 1 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
11 12 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
IN8bio Announces Pricing of Financing Totaling up to $46.9 Million in Private Placement
11 12 2023 09:00:47 提供 Nasdaq GlobeNewswire
-
IN8bio Appoints Dr. Corinne Epperly to Board of Directors
07 12 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
05 12 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
20 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
IN8bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
09 11 2023 16:00:00 提供 Nasdaq GlobeNewswire
-
06 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
03 11 2023 12:00:00 提供 Nasdaq GlobeNewswire
-
02 11 2023 09:17:21 提供 Nasdaq GlobeNewswire
-
IN8bio to Participate at the 2023 Truist Securities BioPharma Symposium
01 11 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
IN8bio Announces Presentations at the Society for Immunology of Cancer (SITC) 38th Annual Meeting
29 9 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
26 9 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
IN8bio to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference
20 9 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
IN8bio Strengthens Intellectual Property Portfolio with Newly Granted Global Patents
19 9 2023 08:03:33 提供 Nasdaq GlobeNewswire
-
IN8bio to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
06 9 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
IN8bio to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference
15 8 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
IN8bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
10 8 2023 16:15:37 提供 Nasdaq GlobeNewswire